Table 4.
Laboratory findings by group among unadjusted and propensity-matched cohorts, stratified by statin therapy.
| Variables | Reference range | Unadjusted data |
P-value | Propensity score matched data |
P-value | ||
|---|---|---|---|---|---|---|---|
| Statin group (N = 179) | No-statin group (N = 663) | Statin group (N = 145) | No-statin group (N = 145) | ||||
| Laboratory findings | |||||||
| White blood cell count, per 109/L | 4.19–9.35 | 6.4 (4.8–9.53) | 5.9 (4.6–7.99) | 0.029 | 6.22 (4.8–9.14) | 6.0 (4.97–8.22) | 0.678 |
| Lymphocytes, per 109/L | 1.13–3.37 | 0.93 (0.66–1.3) | 0.98 (0.7–1.4) | 0.183 | 0.98 (0.695–1.3) | 0.98 (0.68–1.36) | 0.635 |
| Neutrophils, per 109/L | 1.91–6.23 | 4.69 (3.13–7.3) | 4.14 (3–6) | 0.013 | 4.64 (3.17–6.39) | 4.4 (3.36–6.39) | 0.621 |
| Monocytes, per 109/L | 0.29–0.81 | 0.45 (0.3–0.7) | 0.43 (0.3–0.6) | 0.124 | 0.43 (0.3–0.7) | 0.46 (0.33–0.62) | 0.870 |
| Platelet count, per 109/L | 155–360 | 201 (143–282) | 193 (153–252) | 0.401 | 207 (148–277) | 196 (154–241) | 0.355 |
| Haemoglobin, g/dL | 12.0–6.0 | 13.2 (12–14.4) | 13.8 (12.7–14.8) | < .001 | 13.2 (12–14.4) | 13.6 (12.4–15) | 0.037 |
| C-Reactive protein, mg/L | <10 | 20.6 (8.72–67.4) | 18.4 (6.01–67.5) | 0.303 | 20.2 (8.13–99.7) | 36 (11.6–99.7) | 0.021 |
| Lactate dehydrogenase, U/L | 125–360 | 360 (271–492) | 310 (235–404) | 0.001 | 352 (261–473) | 335 (269–403) | 0.328 |
| Creatine phosphokinase, U/L | 29–322 | 134 (73.8–283) | 98 (58–181) | 0.004 | 113 (73.8–289) | 134 (65–229) | 0.156 |
| Creatinine, mg/dL | 0.5–0.95 | 1.04 (0.84–1.4) | 0.92 (0.77–1.1) | < .001 | 1 (0.827–1.33) | 1.01 (0.83–1.3) | 0.728 |
| High-sensitivity cardiac troponin T, ng/L | <14 | 31 (13–50) | 16 (7–40) | < .001 | 31 (13–43) | 32 (17.5–64) | 0.088 |
| D-Dimer, μg/L | <500 | 806 (356–2901) | 918 (490–2228) | 0.739 | 772 (351–3171) | 1566 (572–3171) | 0.404 |
| Chest X-Ray findings, N (%) | |||||||
| Pneumonia on admission | 168 (94) | 578 (87) | 0.013 | 137 (95) | 129 (89) | 0.089 | |
| Pulmonary infiltrations | 131 (73) | 425 (64) | 0.023 | 98 (68) | 106 (73) | 0.305 | |
| Ground-glass opacity | 104 (58) | 330 (50) | 0.048 | 84 (58) | 55 (38) | <.001 | |
| Consolidation lesions | 113 (63) | 313 (47) | < .001 | 88 (61) | 61 (42) | 0.002 | |